Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines

scientific article published on January 1993

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00295188
P698PubMed publication ID8456535

P2093author name stringM Iwamura
P M Sluss
A T Cockett
M Ishibe
P2860cites workCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinomaQ36042397
A cell line from an anaplastic transitional cell carcinoma of human urinary bladderQ36068997
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of actionQ36254770
The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumorsQ37883829
Growth factors in the regulation of pericellular proteolysis: a reviewQ38201615
Signal transmission by the insulin-like growth factorsQ38297337
The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism.Q38332744
Actions of insulin-like growth factorsQ39494147
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.Q39497650
Autocrine growth factors and cancerQ39815279
Evaluation of epidermal growth factor receptors in bladder tumoursQ41153245
A Human Tissue Culture Cell Line from a Transitional Cell Tumour of the Urinary Bladder: Growth, Chromosome Pattern and UltrastructureQ41435917
Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissuesQ41475448
Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42.Q41714675
Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell linesQ41722176
Mechanisms of human bladder tumor invasion: role of protease cathepsin B.Q41722880
The type I insulin-like growth factor receptor is a motility receptor in human melanoma cellsQ41757764
Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cellsQ42118641
Insulin-Like Growth Factor-I Receptors in Human Hyperplastic Prostate Tissue: Characterization, Tissue Localization, and Their Modulation by Chronic Treatment with a Gonadotropin-Releasing Hormone Analog*Q42471023
Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.Q53436869
Growth factors: Mechanism of action and relation to oncogenesQ53552812
The epidermal growth factor receptor and the prognosis of bladder cancer.Q53797133
A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblastsQ54467718
1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3Q68452975
Insulin-like growth factor I receptors in normal and neoplastic human endometriumQ68458403
Normal and malignant human urothelium: in vitro effects of epidermal growth factorQ68818532
Clonal growth of bladder cancer cells in a double layer soft agar assay: needles addition of multiple culture supplementsQ68910587
Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult ratQ69785194
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumoursQ69856767
Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cellsQ70044873
Growth factors and cancerQ70121988
Induced cell differentiation in cancer therapyQ71256750
The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranesQ72125829
P433issue1
P304page(s)27-32
P577publication date1993-01-01
P1433published inUrological ResearchQ15746542
P1476titleCharacterization of insulin-like growth factor I binding sites in human bladder cancer cell lines
P478volume21

Reverse relations

cites work (P2860)
Q39847537Adenosine receptor expression in Escherichia coli-infected and cytokine-stimulated human urinary tract epithelial cells
Q40792637Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity
Q73029129Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer
Q98946845Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma
Q44193476Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration
Q41244257Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer
Q41442987Growth factors in bladder cancer
Q40561027Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells
Q40714046Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Q37381766Implications of insulin-like growth factor-I for prostate cancer therapies
Q34222007Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma
Q34468387Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies
Q54668939Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder.
Q38474624Targeting the IGF-1R: The Tale of the Tortoise and the Hare
Q53407314Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.
Q44085038Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors
Q79199300Urine and serum free IGF-1 levels in patients with bladder cancer: a brief report

Search more.